Capital raised by Hepion Pharmaceuticals
2 Form D filings · first filed Apr 2026 · Red Bank, NJ
Interim Chief Executive Officer
Signatory on Hepion Pharmaceuticals's Form D filings · $3.8M raised across 2
Gary Stetz is on file as Interim Chief Executive Officer at Hepion Pharmaceuticals in Red Bank, NJ. Hepion Pharmaceuticals has 2 Form D filings on record, $3.8M raised in total. Gary Stetz appears as a signatory on the company's filings.
LinkedIn profileA blood-based liquid biopsy test that detects methylated SEPT9 DNA to identify early-stage hepatocellular carcinoma in high-risk patients with cirrhosis.
